A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617Thomas R. Chauncey, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Leukemia Research|2000Cited by 56
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemiaPeter J. Rosen, Frederick R. Appelbaum, Cathryn Rankin et al.|Leukemia Research|2000Cited by 20